Mirum Pharmaceuticals Inc
NASDAQ:MIRM

Watchlist Manager
Mirum Pharmaceuticals Inc Logo
Mirum Pharmaceuticals Inc
NASDAQ:MIRM
Watchlist
Price: 80.21 USD 1.2%
Market Cap: 4.1B USD

Wall Street
Price Targets

MIRM Price Targets Summary
Mirum Pharmaceuticals Inc

Wall Street analysts forecast MIRM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MIRM is 104.35 USD with a low forecast of 80.8 USD and a high forecast of 147 USD.

Lowest
Price Target
80.8 USD
1% Upside
Average
Price Target
104.35 USD
30% Upside
Highest
Price Target
147 USD
83% Upside
Mirum Pharmaceuticals Inc Competitors:
Price Targets
4BB
4Basebio PLC
182% Upside
GLTO
Galecto Inc
24% Upside
RCKT
Rocket Pharmaceuticals Inc
129% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
12% Upside
PBYI
Puma Biotechnology Inc
22% Downside
NTRA
Natera Inc
6% Upside
CGON
CG Oncology Inc
83% Upside
IDYA
IDEAYA Biosciences Inc
45% Upside

Revenue
Forecast

Revenue Estimate
Mirum Pharmaceuticals Inc

The compound annual growth rate of Mirum Pharmaceuticals Inc's revenue for the next 4 years is 27%.

N/A
Past Growth
27%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Mirum Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat

Net Income
Forecast

Net Income Estimate
Mirum Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MIRM's stock price target?
Price Target
104.35 USD

According to Wall Street analysts, the average 1-year price target for MIRM is 104.35 USD with a low forecast of 80.8 USD and a high forecast of 147 USD.

What is Mirum Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
27%

The compound annual growth rate of Mirum Pharmaceuticals Inc's revenue for the next 4 years is 27%.

Back to Top